REQUEST A DEMO
Total
USD $0.00
Search more companies

Adpharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Full name: Adpharma Sp. z o.o. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Adamed Pharma, based in Warsaw, Poland, is a pharmaceutical and biotechnology company. It is a prominent player in the Polish pharmaceutical industry, focusing on developing medicines for chronic civilization diseases. The company has a portfolio of over 500 products available in more than 70 countries and has a strategic partnership with Ecupharma to support expansion in the Italian market. Adamed Pharma is involved in various research and development projects and claims to have a strong presence in the Polish pharmaceutical sector.

Headquarters
Ul. Mariana Adamkiewicza 6
Pienkow; Mazowieckie; Postal Code: 05-152

Contact Details: Purchase the Adpharma Sp. z o.o. report to view the information.

Website: http://adamed.com

Basic Information
Total Employees:
Purchase the Adpharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Adpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Adpharma Sp. z o.o. report to view the information.
Incorporation Date:
July 03, 2006
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Adpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
97.6%
Total operating revenue
97.41%
Operating profit (EBIT)
-24.05%
EBITDA
-24.09%
Net Profit (Loss) for the Period
-28.42%
Total assets
52.51%
Total equity
25.8%
Operating Profit Margin (ROS)
12.29%
Net Profit Margin
12.04%
Return on Equity (ROE)
-7.75%
Quick Ratio
-0.54%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?